ROHTO PHARMACEUTICAL CO.,LTD. Logo

ROHTO PHARMACEUTICAL CO.,LTD.

Multinational company manufacturing OTC pharmaceuticals, skincare, and eye care products.

4527 | T

Overview

Corporate Details

ISIN(s):
JP3982400008
LEI:
Country:
Japan
Address:
大阪市生野区巽西1丁目8番1号

Description

Rohto Pharmaceutical Co., Ltd. is a multinational company that manufactures and markets a wide range of health and beauty care products. The company's core business areas are over-the-counter (OTC) pharmaceuticals and skincare. It is a recognized leader in the eye care market, particularly known for its extensive line of eye drops. The product portfolio also includes skincare, oral medications, and functional foods. Rohto Pharmaceutical focuses on research and development to create innovative products and services that support the physical and mental well-being of consumers worldwide, aiming to contribute to the future potential of society through health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 02:50
確認書
Japanese 9.3 KB
2025-11-14 02:48
半期報告書-第90期(2025/04/01-2026/03/31)
Japanese 282.3 KB
2025-07-11 04:04
訂正確認書
Japanese 9.3 KB
2025-07-11 04:03
訂正有価証券報告書-第89期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2025-07-01 02:29
臨時報告書
Japanese 30.2 KB
2025-06-25 02:08
内部統制報告書-第89期(2024/04/01-2025/03/31)
Japanese 26.7 KB
2025-06-25 02:07
有価証券報告書-第89期(2024/04/01-2025/03/31)
Japanese 1.9 MB
2025-06-25 02:07
確認書
Japanese 9.4 KB
2025-05-12 03:40
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.0 KB
2025-04-14 02:15
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.0 KB
2025-03-14 01:44
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.1 KB
2025-02-27 03:52
訂正臨時報告書
Japanese 37.8 KB
2025-02-26 08:00
臨時報告書
Japanese 44.8 KB
2025-02-13 02:46
大量保有報告書
Japanese 38.2 KB
2024-11-14 02:17
確認書
Japanese 9.5 KB

Automate Your Workflow. Get a real-time feed of all ROHTO PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ROHTO PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ROHTO PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.